Analyst consensus rating
AbCellera Biologics Analyst Rating: Strong Buy
Direct answer
AbCellera Biologics's consensus rating is Strong Buy.
13 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $18.69.
Forecast evidence checked November 22, 2026.
Get free AbCellera Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $9.69
- Average price target
- $18.69
- High price target
- $30.00
- Low price target
- $14.00
- Low target gap
- +44.5%
- Target upside
- +92.9%
- High target gap
- +209.6%
- Target range width
- 165.1%
- Consensus rating
- Strong Buy
- Analysts
- 13
- Evidence date
- November 22, 2026
- Valid through
- November 29, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for AbCellera Biologics?
AbCellera Biologics has a verified Strong Buy consensus. The same dataset has an average price target of $18.69.
How far are AbCellera Biologics's low and high targets from the recorded price?
The low target implies +44.5%, while the high target implies +209.6%.
How many analysts are included in AbCellera Biologics's consensus?
The verified consensus includes 13 analysts.
How is AbCellera Biologics's target upside or downside calculated?
The average target of $18.69 is divided by the recorded price of $9.69, then one is subtracted to produce +92.9%. This does not guarantee a future return.
When was AbCellera Biologics's analyst forecast verified?
The data was verified on 2026-11-22. The dataset is valid through 2026-11-29.